• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2019新型冠状病毒感染患者的皮质类固醇治疗：8例机械通气患者的病例系列

Corticosteroid therapy for 2019-nCoV-infected patients: A case series of eight mechanically ventilated patients.

作者信息

Al-Rasheedi Mabrouk, Alhazmi Yasir, Almaqwashi Nouf, Mateq Ali Alreshidi, Kardam Abdulaziz, Sharaf Mohammod, Haider Khawaja Husnain

机构信息

Albukairyah General Hospital Ministry of Health Albukairyah Saudi Arabia.

Clinical Pharmacy Department King Faisal Medical City Abha Saudi Arabia.

出版信息

Clin Case Rep. 2021 Mar 26;9(5):e04066. doi: 10.1002/ccr3.4066. eCollection 2021 May.

DOI:10.1002/ccr3.4066
PMID:34084491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8142400/
Abstract

High-dose short-term corticosteroid therapy is effective and produces favorable clinical outcome in patients with severe 2019-nCoV infection who are candidates for mechanical ventilation with close monitor/ing for the adverse effect of corticosteroids.

摘要

大剂量短期皮质类固醇治疗对有创机械通气指征的重症2019新型冠状病毒感染患者有效，并能产生良好的临床结局，同时需密切监测皮质类固醇的不良反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1925/8142400/a39b00bf88d8/CCR3-9-e04066-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1925/8142400/a39b00bf88d8/CCR3-9-e04066-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1925/8142400/a39b00bf88d8/CCR3-9-e04066-g001.jpg

相似文献

1
Corticosteroid therapy for 2019-nCoV-infected patients: A case series of eight mechanically ventilated patients.2019新型冠状病毒感染患者的皮质类固醇治疗：8例机械通气患者的病例系列
Clin Case Rep. 2021 Mar 26;9(5):e04066. doi: 10.1002/ccr3.4066. eCollection 2021 May.
2
High-dose, short-term corticosteroids for ARDS caused by COVID-19: a case series.大剂量短期使用皮质类固醇治疗新型冠状病毒肺炎所致急性呼吸窘迫综合征：病例系列研究
Respirol Case Rep. 2020 Jun 4;8(6):e00596. doi: 10.1002/rcr2.596. eCollection 2020 Aug.
3
Corticosteroid Administration and Impaired Glycemic Control in Mechanically Ventilated COVID-19 Patients.皮质类固醇在机械通气 COVID-19 患者中的应用与血糖控制受损。
Semin Cardiothorac Vasc Anesth. 2022 Mar;26(1):32-40. doi: 10.1177/10892532211043313. Epub 2021 Sep 2.
4
Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit.比较 ICU 中 COVID-19 肺炎患者的脉冲剂量和高剂量皮质类固醇与无皮质类固醇治疗。
J Med Virol. 2022 Jan;94(1):349-356. doi: 10.1002/jmv.27351. Epub 2021 Sep 28.
5
Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.糖皮质激素治疗 2019 冠状病毒病相关急性呼吸窘迫综合征：一项倾向评分分析的队列研究。
Crit Care. 2020 Nov 10;24(1):643. doi: 10.1186/s13054-020-03340-4.
6
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.皮质类固醇治疗对 SARS-CoV-2、SARS-CoV 或 MERS-CoV 感染患者结局的影响：系统评价和荟萃分析。
Leukemia. 2020 Jun;34(6):1503-1511. doi: 10.1038/s41375-020-0848-3. Epub 2020 May 5.
7
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.多中心、三臂、随机对照试验研究甲泼尼龙和普通肝素在 SARS-CoV-2 感染肺炎危重症机械通气患者中的应用：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Aug 17;21(1):724. doi: 10.1186/s13063-020-04645-z.
8
Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.地塞米松治疗 ARDS 合并 COVID-19 患者的效果 - 一项前瞻性、多中心、开放标签、平行组、随机对照试验（REMED 试验）：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 1;22(1):172. doi: 10.1186/s13063-021-05116-9.
9
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.新型冠状病毒 2019-nCoV：流行情况、与 SARS-CoV 和 MERS-CoV 的生物学和临床特征比较。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.
10
Adverse events associated with prophylactic corticosteroid use before extubation: a cohort study.拔管前预防性使用皮质类固醇相关的不良事件：一项队列研究。
Ann Transl Med. 2020 Jul;8(14):853. doi: 10.21037/atm-20-1790.

引用本文的文献

1
Editorial: A Compendium of Recent Research on Stem Cell-Based Therapy for Covid-19.社论：基于干细胞治疗新冠病毒病的近期研究综述
Front Cell Dev Biol. 2021 Dec 14;9:813384. doi: 10.3389/fcell.2021.813384. eCollection 2021.

本文引用的文献

1
Characterization of SARS-CoV-2 dynamics in the host.新冠病毒在宿主体内的动态特征
Annu Rev Control. 2020;50:457-468. doi: 10.1016/j.arcontrol.2020.09.008. Epub 2020 Oct 6.
2
Methylprednisolone pulse therapy: An alternative management of severe COVID-19.甲泼尼龙冲击疗法：重症新型冠状病毒肺炎的一种替代治疗方法
Respir Med Case Rep. 2020 Sep 12;31:101221. doi: 10.1016/j.rmcr.2020.101221. eCollection 2020.
3
Therapeutic Options for COVID-19: A Review.新型冠状病毒肺炎的治疗选择：综述
Cureus. 2020 Sep 16;12(9):e10480. doi: 10.7759/cureus.10480.
4
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial.静脉注射甲泼尼龙脉冲治疗住院的严重 COVID-19 患者：一项随机对照临床试验的结果。
Eur Respir J. 2020 Dec 24;56(6). doi: 10.1183/13993003.02808-2020. Print 2020 Dec.
5
Public and healthcare providers awareness of Coronavirus (COVID-19) in Qassim Region, Saudi Arabia.沙特阿拉伯卡西姆地区公众和医疗服务提供者对冠状病毒（COVID-19）的认知情况。
Saudi J Biol Sci. 2021 Jan;28(1):90-98. doi: 10.1016/j.sjbs.2020.08.035. Epub 2020 Sep 10.
6
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.瑞德西韦对比标准治疗对 11 天内中症 COVID-19 患者临床状态的影响：一项随机临床试验。
JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349.
7
Stem cell therapy for COVID-19: Possibilities and challenges.用于 COVID-19 的干细胞治疗：可能性与挑战。
Cell Biol Int. 2020 Nov;44(11):2182-2191. doi: 10.1002/cbin.11440. Epub 2020 Aug 22.
8
Potential Treatment Options for COVID-19: A Comprehensive Review of Global Pharmacological Development Efforts.2019冠状病毒病的潜在治疗方案：全球药理学研发工作的全面综述
Cureus. 2020 Jun 26;12(6):e8845. doi: 10.7759/cureus.8845.
9
Current Overview on Hypercoagulability in COVID-19.新型冠状病毒肺炎患者高凝状态的研究现状。
Am J Cardiovasc Drugs. 2020 Oct;20(5):393-403. doi: 10.1007/s40256-020-00431-z.
10
Pathogenesis of COVID-19-induced ARDS: implications for an ageing population.COVID-19 引发的 ARDS 的发病机制：对老龄化人口的影响。
Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.02049-2020. Print 2020 Sep.